SBIR/STTR Research Award

Rapid and Sensitive Detection of Tuberculosis by MS/MS in Clinical

Award identifier 51bae03893ff2ae57d2965459e06f84edda7e947507aac1bbde5c71ed29bb8e3Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1993

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
ANATRACE, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

PRINCIPAL INVESTIGATOR: Sonesson, Anders AWARDEE ORGANIZATION: Microbial Insights, Inc. 201 Center Park Dr., Suite 1140 Knoxville, TN 37922 TELEPHONE NUMBER: (615) 966-7356 AWARDEE NUMBER: 200-93-0681 In response to the resurgent epidemic of tuberculosis which has been greatly stimulated by the large increase in immuno-compromised persons, it is imperative that rapid and accurate diagnostic tests be available. We propose to establish a test system based on lipid constituents found in the waxes of Mycobacteria for detection and species identification. The "signature" lipids are recovered in sputum, tissue specimens, cerebrospinal fluid, etc., to establish the diagnosis. Components of the Mycobacterial waxes have sufficiently different proportions that they can be used to identify the specific species (which has critical therapeutic implications). Two constituents will be measured. One, tuberulostearic acid is found in the Actinomycetales (of which the Mycobacteria are a part) that can be measured at great sensitivity. The other is a series of multimethyl long chain fatty acids found exclusively in the Mycobacteria. Proportions of mycocersatic acids can be utilized to identify the species of Mycobacteria. These lipids can be quantitatively recovered from clinical specimens and identified chemically without the requirements that the bacteria be isolated and cultured. Application of supercritical fluid extraction (potential one-day sample processing), improved purification methods, with detection by tandem mass spectrometry greatly increase the selectivity and sensitivity (possibly to 6-60 organisms) provide a rapid and quantitative assessment of Mycobacterial infection. Tuberculosis is becoming such an important medical problem that performing this test expeditiously is a viable commercial enterprise.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.